These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 2569812
1. Effects of norakin on respiratory syncytial virus in tissue culture and in mice. Mentel R, Schroeder C, Döhner L. Acta Virol; 1989 Mar; 33(2):162-6. PubMed ID: 2569812 [Abstract] [Full Text] [Related]
3. DSCG reduces RSV-induced illness in RSV-infected mice. Hashimoto K, Mori S, Hashimoto Y, Kaneko H, Ishibashi K, Ishioka K, Kawasaki Y, Peebles RS, Munakata M, Hosoya M, Suzutani T. J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959 [Abstract] [Full Text] [Related]
4. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model. Gualdi L, Mertz S, Gomez AM, Ramilo O, Wittke A, Mejias A. Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300 [Abstract] [Full Text] [Related]
5. [Effects of Alternanthera philoxeroides Griseb against respiratory syncytial virus infection in mice]. Jiang WL, Yang ZQ, Chen W, Xiao H, Luo XL. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):62-4. PubMed ID: 17259148 [Abstract] [Full Text] [Related]
7. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response. Zhang W, Tripp RA. J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323 [Abstract] [Full Text] [Related]
8. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice. Zhou J, Yang XQ, Xie YY, Zhao XD, Jiang LP, Wang LJ, Cui YX. Virus Res; 2007 Dec; 130(1-2):241-8. PubMed ID: 17804108 [Abstract] [Full Text] [Related]
12. [Primary respiratory syncytial virus infection in mice]. Zou Y, Huang H, Xu J. Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):484-6. PubMed ID: 11718040 [Abstract] [Full Text] [Related]
14. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses. Ohol YM, Wang Z, Kemble G, Duke G. PLoS One; 2015 Aug; 10(12):e0144648. PubMed ID: 26659560 [Abstract] [Full Text] [Related]
15. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. Franke-Ullmann G, Pförtner C, Walter P, Steinmüller C, Lohmann-Matthes ML, Kobzik L, Freihorst J. J Immunol; 1995 Jan 01; 154(1):268-80. PubMed ID: 7995946 [Abstract] [Full Text] [Related]
16. A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals. Ojwang JO, Wang YH, Wyde PR, Fischer NH, Schuehly W, Appleman JR, Hinds S, Shimasaki CD. Antiviral Res; 2005 Dec 01; 68(3):163-72. PubMed ID: 16280176 [Abstract] [Full Text] [Related]
18. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model. Ottolini MG, Curtis SR, Mathews A, Ottolini SR, Prince GA. Bone Marrow Transplant; 2002 Jan 01; 29(2):117-20. PubMed ID: 11850705 [Abstract] [Full Text] [Related]
19. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. Miller AL, Bowlin TL, Lukacs NW. J Infect Dis; 2004 Apr 15; 189(8):1419-30. PubMed ID: 15073679 [Abstract] [Full Text] [Related]